Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Giotopoulou (Munich, Germany), S. Behrend (Munich, Germany), G. Ntaliarda (Patras, Greece), A. Lamort (Munich, Germany), M. Pepe (Munich, Germany), I. Lillis (Patras, Greece), M. Spella (Patras, Greece), G. Stathopoulos (Munich, Germany). Mutational RNA signatures in environmentally-induced lung adenocarcinoma. 663

Member's Comments

No comment yet.

Related content which might interest you: PP135 – Mutational RNA signatures in environmentally-induced lung adenocarcinoma Source: ERS Lung Science Conference 2021 Year: 2021 LSC - 2021 - Mutational RNA signatures in environmentally-induced lung adenocarcinoma Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 Causal RNA signatures in lung adenocarcinoma Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 Evolution of microRNA expression during human bronchial squamous carcinogenesis Source: Eur Respir J 2009; 33: 352-359 Year: 2009 Comparative gene expression analysis in lung cancer Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Expression profiling in hypoxic non-small cell lung cancer explants reveals a four-gene hypoxia signature Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Analysis of circular RNAs expression profile in pleural metastases from lung adenocarcinoma Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside Year: 2020 Identifying a tissue specific microRNA molecular signature in lung cancer Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 Differential expression analysis of lncRNA in different types of lung cancer Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 Proteomic analysis of human small cell lung cancer tissues Source: Annual Congress 2009 - Lung cancer biology Year: 2009 LSC Abstract – Transcriptomic profiling of macrophages isolated from human non-small cell lung carcinoma (NSCLC) reveals novel macrophage subsets with distinct tumour response features Source: International Congress 2016 – Lung cancer immunology: latest research Year: 2016 Quantitative methylation profiles of multiple genes in patients with non-small cell lung cancer and its association with clinicopathological correlations Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Hypermethylation pattern in genomic DNA samples derived from tumor and serum of resected non-small cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 674s Year: 2004 Gene expression profiling reveal novel biomarkers in non-small cell lung cancer Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Mutational status of advanced lung adenocarcinoma in a Portuguese cohort Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology Year: 2019 MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD Source: Eur Respir J 2014; 43: 1740-1749 Year: 2014 Profile of WT1 methylation in human lung cancer Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Epigenetic inactivation of checkpoint kinase 2 gene in nonsmall cell lung cancer and its relationship with clinicopathological features Source: Annual Congress 2009 - Lung cancer biology Year: 2009 Where next for lung cancer gene expression profiling? Source: Eur Respir J 2007; 30: 5-6 Year: 2007 Gene expression profile in lung adenocarcinoma and non-cancerous lung tissue Source: Eur Respir J 2005; 26: Suppl. 49, 456s Year: 2005